Project Details
| Short title | AMT-253-01 |
|---|---|
| Status | Active |
| Effective start/end date | 24/11/23 → 15/11/28 |
CTU: First-in-Human, Phase 1 Study of AMT-253, an Anti-MUC18 Antibody-Drug Conjugate, in Patients with Advanced Solid Tumors
- Sabanathan, Dhanusha (Primary Chief Investigator)
- Chapman, Nicola (Clinical Trial Unit Staff)
- TAIDI, Gina (Clinical Trial Unit Staff)
- Chester, Catherine (Clinical Trial Unit Staff)
- Contacos, Christine (Clinical Trial Unit Staff)
Project: Research